ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Lantheus Holdings, Inc. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 77 studies whose lead sponsor is Lantheus Holdings, Inc. or one of 7 companies grouped under it. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 7 registry names, not the registry’s. See them and correct one ↓

Compare Lantheus with Qilu Pharmaceutical and AstraZeneca →

Pipeline: 4 programs

Each counted once: 4 with a study Lantheus Holdings, Inc. leads registered in the last two years.

  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Lantheus Holdings, Inc.’s own registered studies; Lantheus Holdings, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Lantheus Holdings, Inc.’s studies test, most open studies first — 15 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 5 more

Coming up

1 of Lantheus Holdings, Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. 1A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 77 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now45%
  • Under way, not recruiting11%
  • Completed5774%
  • Stopped early1216%Withdrawn 7 · Terminated 5
  • Status unknown or other34%Approved for marketing 1 · Temporarily not available 1 · Status unknown 1

Phase

  • Phase 132
  • Phase 223
  • Phase 313
  • Phase 49

Where

  • United States63
  • Canada11
  • Germany7
  • Finland4
  • Switzerland3
  • Australia3

Over the years

  1. 07
  2. 08
  3. 1209
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 226

By the year each study started; 10 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Lantheus Holdings, Inc.

  • Lantheus Medical Imaging
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    30 studies →
  • Molecular Insight Pharmaceuticals, Inc.
    Acquired — became part of Lantheus Holdings, Inc., Jun 19, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    19 studies →
  • Lantheus Biosciences Ltd.
    Acquired — became part of Lantheus Holdings, Inc., Jul 21, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • Progenics Pharmaceuticals, Inc.
    Acquired — became part of Lantheus Holdings, Inc., Jun 19, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • Life Molecular Imaging SA
    Acquired — became part of Lantheus Holdings, Inc., Jul 21, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • Life Molecular Imaging GmbH
    Acquired — became part of Lantheus Holdings, Inc., Jul 21, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Lantheus Germany GmbH
    Acquired — became part of Lantheus Holdings, Inc., Jul 21, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →

Focus areas

Conditions Lantheus Holdings, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 77. Browse all 77 →